lentivirus expressing shrna constructs (Merck & Co)
Structured Review

Lentivirus Expressing Shrna Constructs, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentivirus+expressing+shrna+constructs/expressing+hairpin+lentiviral+mission+particles+rna+short+shrna+shrna+sirt3+targeting+transduction+trc/pmc12325171-221-19-30
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancer"
Article Title: The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancer
Journal: Theranostics
doi: 10.7150/thno.101393
Figure Legend Snippet: A RNAi screen for the identification of functional regulator of radiation-induced cell plasticity. A . schematic representation of RNAi screening strategy. B-C . Proportion of ALDH br cells in BFP + ( B ) and RFP + SUM159 cells ( C ) following silencing of each individual gene contained in the RNAi library and normalized with non-targeting siRNA (siCTRL). Genes targeted by a siRNA inducing a significant reduction of the ALDH br cell proportion are highlighted. Statistical test used is Student's t-test. Data represent mean ± SD D . Representative images of the high-content screening captures. ALDEFLUOR cellular staining is represented in green. Dead cells are labeled by DRAQ5 in red. RFP+ cells are in yellow and BFP+ cells in blue. E-F . Validation of candidate genes using FACS analysis. Proportion of ALDH br cells in BFP + ( E ) and RFP + SUM159 cells ( F ) are represented normalized with non-targeting siRNA (siCTRL). siRNA targeting ALDH1A1 was used as positive control and siRNA targeting TEXT12 or VDACL were used as negative control. Statistical test used is Student's t-test. Data represent mean ± SD. *p<0.05, **p<0.01, ***p<0.001.
Techniques Used: Functional Assay, High Content Screening, Staining, Labeling, Biomarker Discovery, Positive Control, Negative Control
Figure Legend Snippet: LRP4/YAP axis inhibition radiosensitizes iCSC. A-B . Proportion of cells ( A , SUM159; B , S68) presenting a nuclear location of YAP in each cell subpopulations five days post-irradiation, with representative images of YAP staining (in green) in each cell subpopulations on the right panel. Nuclei are counterstained with DAPi (in blue). C . Pre-ranked GSEA interrogating differential expression between iCSC and late non-CSC and YAP/TAZ target genes. D . Western blot of markers related to YAP/TAZ signaling and its activation in SUM159 and S68 cells silenced for LRP4 (shLRP4) compared to the non-targeting shRNA (shCTRL). The mean intensities are indicated below each band for each condition. E . Heat map representing the mRNA expression of the LRP4, ALDH1A1, and YAP/TAZ target genes in SUM159 and S68 silenced for LRP4 (siLRP4) compared to the non-targeting siRNA (siCTRL). Each row represents three independent replicates per conditions (R1, R2, and R3). F . Proportion of SUM159 cells presenting a nuclear location of YAP in late non-CSC and iCSC following LRP4 silencing (siLRP4) compared to a non-targeting siRNA (siCTRL). G-H . SUM159 ( G ) and S68 cells ( H ), following LRP4 silencing (shLRP4) compared to a non-targeting siRNA (shCTRL), were exposed to various dose of radiation therapy and subjected to clonogenic survival assays ( G ), with representative images (right panels). I . Patient-derived xenograft organoid (PDXO) size distribution for CRCM389 cells WT (shCTRL) or silenced for LRP4 (shLRP4) following irradiation (RT) and compared to untreated condition (CTRL) (left panel). Representative pictures of PDXO-CRCM389 7 days post-treatment (right panel). Statistical test used is Student's t-test. Data represent mean ± SD. ns (not significant), *p<0.05, **p<0.01, ***p<0.001. J . Kaplan-Meier tumor-free survival curves of mice xenografted with 100,000-200,000 SUM159 irradiated cells silenced for LRP4 (shLRP4) compared to the control (shCTRL). p-value and hazard ration (HR) estimated according to Log-rank (Mantel-Cox) test.
Techniques Used: Inhibition, Irradiation, Staining, Quantitative Proteomics, Western Blot, Activation Assay, shRNA, Expressing, Derivative Assay, Control
Related Articles
Multiple Displacement Amplification:Article Title: The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancer Article Snippet: Probe; YAP1 (Hs00902712_g1), AXL (Hs01064444_m1), NT5E (Hs00159686_m1), CYR61 (Hs00155479_m1), ARHGEF17 (Hs00998246_m1), ASAP1 (Hs00987469_m1), RBMS3 (Hs01104892_m1), GADD45A (Hs00169255_m1), AMOTL2 (Hs01048101_m1), CCDC80 (Hs00277341_m1), MYOF (Hs00203853_m1), FOXF2 (Hs00230963_m1), PTPN14 (Hs00193643_m1), CRIM1 (Hs01070663_m1), LATS2 (Hs01059009_m1), DOCK5 (Hs00227848_m1), CTGF (Hs00170014_m1), ANKRD1 (Hs00173317_m1), NUAK2 (Hs01011402_m1), IGFBP3 (Hs00181211_m1), TGFB2 (Hs00234244_m1), FJX1 (Hs00534909_s1), F3 (Hs01076029_m1). .. To evaluate the effect of LRP4 silencing on radiotherapy-response, SUM159, S68, and MDA-MB-231 cells were first transduced with a Transduction:Article Title: The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancer Article Snippet: Probe; YAP1 (Hs00902712_g1), AXL (Hs01064444_m1), NT5E (Hs00159686_m1), CYR61 (Hs00155479_m1), ARHGEF17 (Hs00998246_m1), ASAP1 (Hs00987469_m1), RBMS3 (Hs01104892_m1), GADD45A (Hs00169255_m1), AMOTL2 (Hs01048101_m1), CCDC80 (Hs00277341_m1), MYOF (Hs00203853_m1), FOXF2 (Hs00230963_m1), PTPN14 (Hs00193643_m1), CRIM1 (Hs01070663_m1), LATS2 (Hs01059009_m1), DOCK5 (Hs00227848_m1), CTGF (Hs00170014_m1), ANKRD1 (Hs00173317_m1), NUAK2 (Hs01011402_m1), IGFBP3 (Hs00181211_m1), TGFB2 (Hs00234244_m1), FJX1 (Hs00534909_s1), F3 (Hs01076029_m1). .. To evaluate the effect of LRP4 silencing on radiotherapy-response, SUM159, S68, and MDA-MB-231 cells were first transduced with a Expressing:Article Title: The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancer Article Snippet: Probe; YAP1 (Hs00902712_g1), AXL (Hs01064444_m1), NT5E (Hs00159686_m1), CYR61 (Hs00155479_m1), ARHGEF17 (Hs00998246_m1), ASAP1 (Hs00987469_m1), RBMS3 (Hs01104892_m1), GADD45A (Hs00169255_m1), AMOTL2 (Hs01048101_m1), CCDC80 (Hs00277341_m1), MYOF (Hs00203853_m1), FOXF2 (Hs00230963_m1), PTPN14 (Hs00193643_m1), CRIM1 (Hs01070663_m1), LATS2 (Hs01059009_m1), DOCK5 (Hs00227848_m1), CTGF (Hs00170014_m1), ANKRD1 (Hs00173317_m1), NUAK2 (Hs01011402_m1), IGFBP3 (Hs00181211_m1), TGFB2 (Hs00234244_m1), FJX1 (Hs00534909_s1), F3 (Hs01076029_m1). .. To evaluate the effect of LRP4 silencing on radiotherapy-response, SUM159, S68, and MDA-MB-231 cells were first transduced with a shRNA:Article Title: The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancer Article Snippet: Probe; YAP1 (Hs00902712_g1), AXL (Hs01064444_m1), NT5E (Hs00159686_m1), CYR61 (Hs00155479_m1), ARHGEF17 (Hs00998246_m1), ASAP1 (Hs00987469_m1), RBMS3 (Hs01104892_m1), GADD45A (Hs00169255_m1), AMOTL2 (Hs01048101_m1), CCDC80 (Hs00277341_m1), MYOF (Hs00203853_m1), FOXF2 (Hs00230963_m1), PTPN14 (Hs00193643_m1), CRIM1 (Hs01070663_m1), LATS2 (Hs01059009_m1), DOCK5 (Hs00227848_m1), CTGF (Hs00170014_m1), ANKRD1 (Hs00173317_m1), NUAK2 (Hs01011402_m1), IGFBP3 (Hs00181211_m1), TGFB2 (Hs00234244_m1), FJX1 (Hs00534909_s1), F3 (Hs01076029_m1). .. To evaluate the effect of LRP4 silencing on radiotherapy-response, SUM159, S68, and MDA-MB-231 cells were first transduced with a Construct:Article Title: The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancer Article Snippet: Probe; YAP1 (Hs00902712_g1), AXL (Hs01064444_m1), NT5E (Hs00159686_m1), CYR61 (Hs00155479_m1), ARHGEF17 (Hs00998246_m1), ASAP1 (Hs00987469_m1), RBMS3 (Hs01104892_m1), GADD45A (Hs00169255_m1), AMOTL2 (Hs01048101_m1), CCDC80 (Hs00277341_m1), MYOF (Hs00203853_m1), FOXF2 (Hs00230963_m1), PTPN14 (Hs00193643_m1), CRIM1 (Hs01070663_m1), LATS2 (Hs01059009_m1), DOCK5 (Hs00227848_m1), CTGF (Hs00170014_m1), ANKRD1 (Hs00173317_m1), NUAK2 (Hs01011402_m1), IGFBP3 (Hs00181211_m1), TGFB2 (Hs00234244_m1), FJX1 (Hs00534909_s1), F3 (Hs01076029_m1). .. To evaluate the effect of LRP4 silencing on radiotherapy-response, SUM159, S68, and MDA-MB-231 cells were first transduced with a Irradiation:Article Title: The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancer Article Snippet: Probe; YAP1 (Hs00902712_g1), AXL (Hs01064444_m1), NT5E (Hs00159686_m1), CYR61 (Hs00155479_m1), ARHGEF17 (Hs00998246_m1), ASAP1 (Hs00987469_m1), RBMS3 (Hs01104892_m1), GADD45A (Hs00169255_m1), AMOTL2 (Hs01048101_m1), CCDC80 (Hs00277341_m1), MYOF (Hs00203853_m1), FOXF2 (Hs00230963_m1), PTPN14 (Hs00193643_m1), CRIM1 (Hs01070663_m1), LATS2 (Hs01059009_m1), DOCK5 (Hs00227848_m1), CTGF (Hs00170014_m1), ANKRD1 (Hs00173317_m1), NUAK2 (Hs01011402_m1), IGFBP3 (Hs00181211_m1), TGFB2 (Hs00234244_m1), FJX1 (Hs00534909_s1), F3 (Hs01076029_m1). .. To evaluate the effect of LRP4 silencing on radiotherapy-response, SUM159, S68, and MDA-MB-231 cells were first transduced with a |
Figure 1 . (D) SNP-SELEX results for variant rs35342456. (E) EMSA with nuclear extract (NE) from MIN6 cells showing preferential binding to the reference allele. (F) Zoom in of the locus showing location of variant rs35342456 (yellow line) in a cytokine-responsive beta cell cCRE with co-accessibility and 3D interaction to the SOCS1 promoter in cytokine-treated and untreated EndoC-βH1 cells. For 3D interactions, virtual 4C counts are scaled between 0 and 1. (G) Counts of each sgRNA in the CRISPR-KO screen targeting SOCS1 in untreated and high-dose cytokine EndoC-βH1, normalized to the sequencing depth of each sample. Effect size and uncorrected p value from MAGeCK. (H) Normalized expression of SOCS1 in human islet samples in cytokines. Log 2 fold change and uncorrected p values from DESeq2 comparing high-dose three-cytokine (red) and untreated (purple). (I) Quantification of apoptotic EndoC-βH1 cells with shRNA targeting SOCS1 or scramble in either high-dose cytokine or vehicle (0.1% BSA). Values are mean and error bars are SD from n = 4 transductions, and p values are shown from two-way ANOVA followed by pairwise comparisons using Tukey’s HSD. " width="250" height="auto" />